Your browser doesn't support javascript.
loading
Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies.
Marshall, Catherine Handy; Chen, Yongmei; Kuo, Claire; Cullen, Jennifer; Jiang, Jiji; Rosner, Inger; Markowski, Mark; McLeod, David G; Trock, Bruce J; Eisenberger, Mario A.
Afiliação
  • Marshall CH; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Marylands.
  • Chen Y; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of Health Sciences, Bethesda, Marylands.
  • Kuo C; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of Health Sciences, Bethesda, Marylands.
  • Cullen J; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of Health Sciences, Bethesda, Marylands.
  • Jiang J; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Marylands.
  • Rosner I; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of Health Sciences, Bethesda, Marylands.
  • Markowski M; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Marylands.
  • McLeod DG; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of Health Sciences, Bethesda, Marylands.
  • Trock BJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Marylands.
  • Eisenberger MA; Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of Health Sciences, Bethesda, Marylands.
J Urol ; 206(3): 623-629, 2021 09.
Article em En | MEDLINE | ID: mdl-34003011

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Calicreínas / Antígeno Prostático Específico / Tempo para o Tratamento / Antagonistas de Androgênios / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Urol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Calicreínas / Antígeno Prostático Específico / Tempo para o Tratamento / Antagonistas de Androgênios / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Urol Ano de publicação: 2021 Tipo de documento: Article